lidor vet. 20 mg/ml injektioneste, liuos
vetviva richter gmbh - lidocaine hydrochloride monohydrate - injektioneste, liuos - 20 mg/ml - lidokaiini
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
imatinib stada 100 mg kapseli, kova
stada arzneimittel ag - imatinib mesylate - kapseli, kova - 100 mg - imatinibi
imatinib stada 400 mg kapseli, kova
stada arzneimittel ag - imatinib mesylate - kapseli, kova - 400 mg - imatinibi
imatinib aristo 100 mg tabletti, kalvopäällysteinen
aristo pharma gmbh - imatinibi mesylas - tabletti, kalvopäällysteinen - 100 mg - imatinibi
imatinib aristo 400 mg tabletti, kalvopäällysteinen
aristo pharma gmbh - imatinibi mesylas - tabletti, kalvopäällysteinen - 400 mg - imatinibi